Gastric carcinoma: when is palliative gastrectomy justified?

  • Hubert Scheidbach | scheidbach@t-online.de Department of General, Abdominal and Vascular Surgery, Otto-von-Guericke University, Magdeburg, Germany.
  • Hans Lippert Department of General, Abdominal and Vascular Surgery, Otto-von-Guericke University, Magdeburg, .
  • Frank Meyer Department of General, Abdominal and Vascular Surgery, Otto-von-Guericke University, Magdeburg, .

Abstract

Gastric carcinoma is frequently diagnosed with an advanced stage of non-curable tumor growth characterized by infiltration of the gastric serosa, peritoneal tumor spread and/or metastases within lymph nodes and liver. Currently, there is a controversy on the value of palliative resection with regard to the safety and benefit to the patient outcome. Based on the available literature, this overview summarizes the various aspects and interprets the limited data on the palliative resection of gastric carcinoma. It turns out that the available study results may indicate potential for an improved quality of life and a prolongation of survival if an acceptable morbidity and mortality are present.

Downloads

Download data is not yet available.
Published
2011-12-05
Section
Reviews
Keywords:
Gastric carcinoma - Palliative resection - Survival - Morbidity - Mortality - Quality of life
Statistics
Abstract views: 1015

FULL TEXT: 182
Share it

PlumX Metrics

PlumX Metrics provide insights into the ways people interact with individual pieces of research output (articles, conference proceedings, book chapters, and many more) in the online environment. Examples include, when research is mentioned in the news or is tweeted about. Collectively known as PlumX Metrics, these metrics are divided into five categories to help make sense of the huge amounts of data involved and to enable analysis by comparing like with like.

How to Cite
Scheidbach, H., Lippert, H., & Meyer, F. (2011). Gastric carcinoma: when is palliative gastrectomy justified?. Oncology Reviews, 4(2), 127-132. https://doi.org/10.4081/oncol.2010.127